Literature DB >> 22779237

Chloramphenicol with fluid and electrolyte therapy cures terminally ill green tree frogs (Litoria caerulea) with chytridiomycosis.

Sam Young1, Rick Speare, Lee Berger, Lee F Skerratt.   

Abstract

Terminal changes in frogs infected with the amphibian fungal pathogen Batrachochytrium dendrobatidis (Bd) include epidermal degeneration leading to inhibited epidermal electrolyte transport, systemic electrolyte disturbances, and asystolic cardiac arrest. There are few reports of successful treatment of chytridiomycosis and none that include curing amphibians with severe disease. Three terminally ill green tree frogs (Litoria caerulea) with heavy Bd infections were cured using a combination of continuous shallow immersion in 20 mg/L chloramphenicol solution for 14 days, parenteral isotonic electrolyte fluid therapy for 6 days, and increased ambient temperature to 28 degrees C for 14 days. All terminally ill frogs recovered rapidly to normal activity levels and appetite within 5 days of commencing treatment. In contrast, five untreated terminally ill L. caerulea with heavy Bd infections died within 24-48 hr of becoming moribund. Subclinical infections in 15 experimentally infected L. caerulea were cured within 28 days by continuous shallow immersion in 20 mg/L chloramphenicol solution without adverse effects. This is the first known report of a clinical treatment protocol for curing terminally ill Bd-infected frogs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22779237     DOI: 10.1638/2011-0231.1

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  8 in total

1.  Reduced itraconazole concentration and durations are successful in treating Batrachochytrium dendrobatidis infection in amphibians.

Authors:  Laura A Brannelly
Journal:  J Vis Exp       Date:  2014-03-14       Impact factor: 1.355

2.  Evaluation of amphotericin B and chloramphenicol as alternative drugs for treatment of chytridiomycosis and their impacts on innate skin defenses.

Authors:  Whitney M Holden; Alexander R Ebert; Peter F Canning; Louise A Rollins-Smith
Journal:  Appl Environ Microbiol       Date:  2014-04-25       Impact factor: 4.792

3.  Treatment trial of clinically ill corroboree frogs with chytridiomycosis with two triazole antifungals and electrolyte therapy.

Authors:  Laura A Brannelly; Lee F Skerratt; Lee Berger
Journal:  Vet Res Commun       Date:  2015-08-06       Impact factor: 2.459

4.  In vitro modeling of Batrachochytrium dendrobatidis infection of the amphibian skin.

Authors:  Elin Verbrugghe; Pascale Van Rooij; Herman Favoreel; An Martel; Frank Pasmans
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

5.  Predicting in vivo absorption of chloramphenicol in frogs using in vitro percutaneous absorption data.

Authors:  Victoria K Llewelyn; Lee Berger; Beverley D Glass
Journal:  BMC Vet Res       Date:  2021-01-28       Impact factor: 2.741

6.  Exposure to Batrachochytrium dendrobatidis affects chemical defences in two anuran amphibians, Rana dalmatina and Bufo bufo.

Authors:  János Ujszegi; Krisztina Ludányi; Ágnes M Móricz; Dániel Krüzselyi; László Drahos; Tamás Drexler; Márk Z Németh; Judit Vörös; Trenton W J Garner; Attila Hettyey
Journal:  BMC Ecol Evol       Date:  2021-07-03

7.  Defects in host immune function in tree frogs with chronic chytridiomycosis.

Authors:  Sam Young; Paul Whitehorn; Lee Berger; Lee F Skerratt; Rick Speare; Stephen Garland; Rebecca Webb
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

8.  Using stochastic epidemiological models to evaluate conservation strategies for endangered amphibians.

Authors:  Brian Drawert; Marc Griesemer; Linda R Petzold; Cheryl J Briggs
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.